Cancer Drug Parity Act of 2026

Hozzl · 2026-07-30T17:58:21Z

Explore the details of Senate Bill 5004 Cancer Drug Parity Act of 2026 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

7/30/2026, 5:58 PM

Summary of Bill S 5004

The bill "A bill to amend the Employee Retirement Income Security Act of 1974" in the 119th Congress (Session 119) aims to mandate group health plans to ensure that cost-sharing for oral anticancer drugs is no less favorable than cost-sharing for anticancer medications administered by a health care provider. The bill was introduced on July 15, 2026.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 5004

Bill S 5004 is currently in the status of Bill Introduced since July 15, 2026. Bill S 5004 was introduced during Congress 119 and was introduced to the Senate on July 15, 2026. Bill S 5004's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of July 15, 2026

Bipartisan Support of Bill S 5004

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 5004

Primary Policy Focus

Health

Alternate Title(s) of Bill S 5004

A bill to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider.